CClinicalTrials.gg
CompletedNCT06740864Updated Mar 18, 2026

40 Hz Transcranial Alternating Current Stimulation for Inducing Gamma Oscillations

An interventional study of Transcranial alternating current stimulation and Transcranial alternating current stimulation in Alzheimer Disease and Cognitive Decline, sponsored by The National Brain Mapping Laboratory (NBML). Completed at 1 site in Iran. Open to participants aged 50 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-18.

Sponsored by The National Brain Mapping Laboratory (NBML) · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jun 2024, registered Dec 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
50 Years to 85 Years
Sex
All
01

Study summary

This study aims to compare the efficacy of different 40 Hz tACS protocols in entraining gamma oscillations, which are linked to various cognitive functions and play a significant role in cognitive impairments like Alzheimer's disease. Specifically, it examines the effects of 40 Hz tACS applied to frontal brain regions versus fronto-temporal regions on gamma oscillations and working memory in healthy elderly individuals.

02

Conditions studied

  • Alzheimer Disease
  • Cognitive Decline
03

In context

Alzheimer Disease

3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.

This study's enrollment of 30 is below the median of 70 across 2,808 interventional studies indexed under Alzheimer Disease.

Browse Alzheimer Disease studies →

Lead sponsor

The National Brain Mapping Laboratory (NBML) is the lead sponsor of 11 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy elderly between 50-80 years of age
  • normal or corrected to normal eye vision
  • right-handed
  • non-smokers
  • at least 70 % accuracy in working memory training task

Exclusion criteria

Exclusion Criteria:

  • history of neurological or psychiatric disorders including seizures or epilepsy,
  • Taking CNS, blood pressure and other medications
  • having metal implants in the head and neck
  • significant cognitive decline meassured by The Montreal Cognitive Assessment (MoCA)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    40 Hz prefrontal Transcranial alternating current stimulation

    During prefrontal tACS, an alternating electrical current with a 1 milliamp peak-to-peak amplitude will be delivered, featuring a 15-second ramp-up at the start and a 15-second ramp-down at the end. The stimulation duration is 20 minutes and four channels are used for delivering sinusoidal alternating currents to the head. The alternating current was delivered to the prefrontal cortex bilaterally with the electrodes at F3 and F4 and the return electrodes were placed at the ipsilateral mastoids at TP9 and TP10 (international 10-20 EEG electrode placement system).

    Device: Transcranial alternating current stimulation

  • Active comparator
    40 Hz frontal-temporal Transcranial alternating current stimulation

    During frontal-temporal tACS, an alternating electrical current with a personalized peak-to-peak stimulation intensity will be delivered, featuring a 15-second ramp-up at the start and a 15-second ramp-down at the end. The stimulation duration is 20 minutes and four channels are used for delivering sinusoidal alternating currents to the head. The alternating current was delivered to the prefrontal and temporal cortices with the active electrodes at AF3-T7 and the return electrodes over AF4-T8 (according international 10-20 EEG electrode placement system).

    Device: Transcranial alternating current stimulation

  • Sham comparator
    sham Transcranial alternating current stimulation

    During sham tACS, an alternating artificial electrical current will be delivered, only ramping the current for 15 seconds up and 15 seconds down at the beginning and end of the stimulation respectively.

    Device: Sham Transcranial alternating current stimulation

Interventions

  • DeviceTranscranial alternating current stimulation

    Transcranial alternating current will be delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain). Circular carbon rubber electrodes (2cm radius, 12,57 cm2) are used throughout the stimulation.

  • DeviceTranscranial alternating current stimulation

    Transcranial alternating current will be delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain). Circular carbon rubber electrodes (2cm radius, 12,57 cm2) are used throughout the stimulation.

  • DeviceSham Transcranial alternating current stimulation

    Sham tACS will be applied by only ramping the current for 15 seconds up and 15 seconds down at the beginning and end of the stimulation respectively.

06

What researchers measure

Primary outcomes

  1. Working Memory behavioral performance

    Participants view a continuous sequence of alphabet letters, presented as stimuli in Arial font, size 120pt, on a tube screen positioned at 60cm eye distance. The stimuli are shown with a time interval of two seconds between them. The task consisted of six blocks with 70 stimuli, including 12 possible hit trials. Participants were instructed to press the left key on a response box if the presented stimulus matched either the one presented one trial prior (1-Back) or three trials prior (3-Back). In all other cases, participants press the right key. The left button is pressed with the index finger, while the right button is pressed with the middle finger of the right hand, with buttons aligned horizontally. The response condition varied by block, with three blocks for 3-Back and three for 1-Back, and the order was counterbalanced across participants and sessions.

    Time frame: During procedure (20 minutes)

  2. electroencephalogram (EEG) oscillatory power

    Change in the EEG power in the gamma band

    Time frame: up to 2 hours after the intervention

  3. electroencephalogram (EEG) functional connectivity

    Change in EEG functional connectivity, specifically global efficiency, coherence, and phase-locking value at gamma frequency

    Time frame: up to 2 hours after the intervention

Secondary outcomes

  1. electroencephalogram (EEG) oscillatory power

    Change in the EEG power in alpha, delta, theta and beta bands

    Time frame: up to 2 hours after the intervention

07

Study locations

1 site
  • Institute for Research in Fundamental Sciences
    Tehran, Iran
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06740864
Lead sponsor
The National Brain Mapping Laboratory (NBML)
Collaborators
Technical University of Dortmund, Leibniz Research Centre for Working Environment and Human Factors, Institute for Research in Fundamental Sciences (IPM)
Responsible party
Mohammad Ali Salehinejad (Principal Investigator, Technical University of Dortmund) — Principal investigator
First posted
Dec 18, 2024
Start date
Jun 1, 2024
Primary completion
Feb 1, 2025
Completion
Jun 1, 2025
Last update
Mar 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion